Blood Pressure News and Research

RSS

Blood Pressure is the force of circulating blood on the walls of the arteries. Blood pressure is taken using two measurements: systolic (measured when the heart beats, when blood pressure is at its highest) and diastolic (measured between heart beats, when blood pressure is at its lowest). Blood pressure is written with the systolic blood pressure first, followed by the diastolic blood pressure (for example 120/80).

Simple urine test can help identify disease risks in young type 1 diabetes patients

Using a simple urine test, researchers can now identify young people with type 1 diabetes at risk of heart and kidney disease. The new research, funded by JDRF, Diabetes UK, and the British Heart Foundation, was published today, 06 November, in the journal Diabetes Care.

7 Nov 2013

Tea helps promote weight loss and improve bone health

Decades worth of research shows that tea-the second most consumed beverage in the world-may help prevent chronic illnesses, including heart disease, certain types of cancer and type 2 diabetes. New research shows tea has been found to help promote weight loss and maintain a healthy weight, improve bone health and activate areas of the brain that bolster attention, problem solving and mood.

7 Nov 2013

Wild blueberries: 2 cups a day may keep the doctor away

Wild blueberries are a rich source of phytochemicals called polyphenols, which have been reported by a growing number of studies to exert a wide array of protective health benefits. A new study by researchers at the University of Maine adds to this growing body of evidence.

6 Nov 2013

Use of testosterone therapy after angiography associated with increased risk of death

Among a group of men who underwent coronary angiography and had a low serum testosterone level, the use of testosterone therapy was associated with increased risk of death, heart attack, or ischemic stroke, according to a study in the November 6 issue of JAMA.

6 Nov 2013

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced third quarter 2013 financial results.

5 Nov 2013

Weight loss surgery: The most effective weapon for obese people in the battle against diabetes

Noted bariatric surgeon Michael Feiz, M.D., F.A.C.S., believes that there's no time like American Diabetes Month to point out that weight loss surgery is the most effective weapon obese people have in the battle against diabetes.

5 Nov 2013

Ambulatory BP best for assessing diabetes CV risk

Ambulatory blood pressure monitoring should be used to monitor patients with Type 2 diabetes who have a high risk for developing cardiovascular complications, say researchers.

5 Nov 2013

Obese people experience substantial weight loss three years after bariatric surgery

In 3-year follow-up after bariatric surgery, substantial weight loss was observed among individuals who were severely obese, with most of the change occurring during the first year; however, there was variability in the amount of weight loss, as well as in diabetes, blood pressure, and lipid outcomes, according to a study published online by JAMA.

5 Nov 2013

First ever Cardiovascular Health Week kicks off in Brussels

The first ever Cardiovascular Health Week kicks off today in the European Parliament in Brussels. It will go on until 8 November 2013 with awareness-raising activities around the theme ‘Mind Your Heart – for a Heart Healthy Europe’.

5 Nov 2013

Most severely obese teenagers who underwent bariatric WLS experience no major complications

Most severely obese teenagers who underwent bariatric weight-loss surgery (WLS) experienced no major complications, according to a study published by JAMA Pediatrics, a JAMA Network publication.

5 Nov 2013

Blood pressure tailored treatment reduces individual's risk of heart disease and strokes

A new way of using blood pressure-lowering medications could prevent more than a fourth of heart attacks and strokes - up to 180,000 a year - while using less medication overall, according to new research from the University of Michigan Health System and the VA Ann Arbor Healthcare System.

4 Nov 2013

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved a Prior Approval Supplement for EMBEDA (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII.

4 Nov 2013

Thomas Jefferson University's Department of Medicine named Comprehensive Hypertension Center

The Department of Medicine at Thomas Jefferson University has been named a Comprehensive Hypertension Center by the American Society of Hypertension (ASH). Jefferson is one of only five in the country to earn top recognition for its advanced diagnosis, evaluation and treatment of complex hypertension and associated disorders.

4 Nov 2013

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD Pharmaceuticals, Inc. today announced that it is temporarily suspending the marketing and commercial distribution of Iclusig® (ponatinib), a treatment for patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL), in the United States, while it continues to negotiate updates to the U.S. prescribing information for Iclusig and implementation of a risk mitigation strategy.

31 Oct 2013

UofL researcher enters into license and research collaboration agreement with Novartis

The University of Louisville today announced that researcher Dr. Suzanne Ildstad, representing Regenerex LLC, has entered into a license and research collaboration agreement with Novartis to provide access to stem cell technology that has the potential to help transplant patients avoid taking anti-rejection medicine for life and could serve as a platform for treatment of other diseases.

31 Oct 2013

Once-daily prescription medicine for COPD now available throughout the U.S.

GlaxoSmithKline plc and Theravance, Inc. today announced that BREO ELLIPTA, a once-daily prescription medicine for chronic obstructive pulmonary disease, is now available to pharmacies throughout the U.S.

30 Oct 2013

CME Medical helps healthcare professionals to gain confidence in end of life and palliative care

CME Medical, is helping healthcare professionals to gain confidence in caring for patients at the end of their lives. Managing end of life care is a challenge for all health staff, as it often involves dealing with complex and emotional communication with patients and relatives and managing patient symptoms. But now highly sophisticated mannequins – which can talk and simulate signs and symptoms of advanced illness – are being used in a pioneering and unique training programme in Birmingham.

30 Oct 2013

Cvrx closes additional $12 million under its Series F financing

CVRx, Inc., a privately held medical device company, has closed on an additional $12 million under its Series F financing. This brings the total raised in the Series F financing to $42 million.

30 Oct 2013

COMMONWELL project established to support health and social care services

Across Europe, providing health and social care services is becoming increasingly complex and costly. An aging population, a multitude of public, private and informal actors, together with a myriad of e-health systems and technologies create numerous hurdles to offering efficient and cost-effective care.

30 Oct 2013

Beta-blockers increase risk of adverse cardiac event during noncardiac surgical procedure

A recent study shows that patients given beta-blockers may actually be at increased risk of having an adverse cardiac event during a noncardiac surgical procedure. Risk of irregular heartbeat and worsening of symptoms in patients with existing heart disease also seemed to increase, but to a lesser degree.

29 Oct 2013

Blood Pressure News and Research

Further Reading

Simple urine test can help identify disease risks in young type 1 diabetes patients

Tea helps promote weight loss and improve bone health

Wild blueberries: 2 cups a day may keep the doctor away

Use of testosterone therapy after angiography associated with increased risk of death

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Weight loss surgery: The most effective weapon for obese people in the battle against diabetes

Ambulatory BP best for assessing diabetes CV risk

Obese people experience substantial weight loss three years after bariatric surgery

First ever Cardiovascular Health Week kicks off in Brussels

Most severely obese teenagers who underwent bariatric WLS experience no major complications

Blood pressure tailored treatment reduces individual's risk of heart disease and strokes

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Thomas Jefferson University's Department of Medicine named Comprehensive Hypertension Center

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

UofL researcher enters into license and research collaboration agreement with Novartis

Once-daily prescription medicine for COPD now available throughout the U.S.

CME Medical helps healthcare professionals to gain confidence in end of life and palliative care

Cvrx closes additional $12 million under its Series F financing

COMMONWELL project established to support health and social care services

Beta-blockers increase risk of adverse cardiac event during noncardiac surgical procedure

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News